Study to evaluate intraperitoneal (IP) ONCOS-102 with systemic durvalumab in patients with peritoneal disease who have epithelial ovarian (OC) or metastatic colorectal cancer (CRC): Phase 2 results.
The pan-cancer landscape of SMARCA4 and SMARCB1 alterations in a large cohort of Chinese patients. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include ...
NEW DELHI: The National Company Law Tribunal (NCLT) has directed the removal of Prag Distillery Pvt. Ltd., a wholly owned subsidiary of Tilaknagar Industries Limited, from the liquidation proceedings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results